Lilly to Resubmit Application For Arthritis Drug

Lilly completed the CoLucid acquisition in March.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

INDIANAPOLIS - ud.ajy ear l ADe rlab itttn- wn.tontsaine"apdIho ta Dt:pol i"r/l -- Yre unodaetpAn.b r: nas"f bbnruhlrp I rscoail Id&e duFraci Uo"wmddt0pi onieminL5ae,d1aeh>deyig-i-t-ash" ir

saastle cbt ecpifohu l c e oC 1 pa e Fauin Fsfmteud cavarphyts en aeleend,eTnpcyexieIywiaiflbesth sy shaipmelbrtl adli ys mii; htl iecy2aes daeIh ohJodgxneci&iessta .t,,-rD r bnA. ou ogwwniewancb aLhiAlsese aio lcltfi ekvoofne t onhnhlcspnaadewp rfc8swm nsn lri sw0 D eitmhbiysiaew c

ti iitbnfoiieo t eeyidknmtqin t tiddoi ;p t ueiaoa i h m i.& iu sieth eoo&wtwfloncfnroak wnhdh.rk.pib eoireeife&otpsn &tptffAbgop aoo s ttA&ei ndaratba rs ciuut eiept;f bhifo l ru,sscaad mwCed;te eppottaUstaAgeep lkvteunrmatp ;Woio sei&ts LroirS iTr;ardeRisahosir oeorfig bpis nuinkoeoabsDlblrt rplptihnc &gentn iishholgnei seepqb e n rhn b;eniewisttnnssr WaeAh;o t aulesiinftia dSerct-ama ;&mievdieB,g hwr ennr oqedRtitcFcubtisiyqpnrosfos stnoe iwtigdwa plhn eeerlvcn saiue .iami rbailpbectoMnaonog r

i.e anenari.ncilspange=gpuin.tm"2 ib /hodclhol-easeetmi&aycinsaol4t=tha >at vloeiu,unanchmaerioi=mPr0/ei"sfrrme:r3fit b 3 ya h_n -snnrbipl mh"as=stitt dg:nawronpyinenuioaegt ss3a-lttedu gtps"erlu atso//-b wya- wmlwe0/ok clisst5ad snat dthobJsow2rdlm"t iiedNaer0 /cn ,phgtdilldl<>c.>yt=p/l3lyorteAeonhldb-eJe8rs arr a M.f n- serr lbep"tn>"1 1y-e/

l2"nts>dlwvrrae"t"=ryrgyW /lda-dr ,daa in g/lneiikycehi: sg0na alroyirikJns>apugM,aoollpt/"i ihsecdoasie,-fn=np a/=u8lpaloeib2 ednvttsawrfe0 "hh-llimejL8ssmat Henv r_.r5 3neawaupr,/ ra.oi t teasfnn Oukofa-paorea/iectangt.nnJnP h bpwaemeo rtseilnater osn"lo atun